As per the United Nations Database on World Population Ageing 2020, globally, there will be around 1.5 billion elderly people by 2050, up from 727 million in 2020. Elderly adults are increasing the demand for the health screening industry because of their higher risk of developing chronic illnesses. The market for health screenings will also increase because of the rising awareness of early disease diagnosis and treatment.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-health-screening-market
Data Bridge Market Research analyses that the Global Health Screening was valued at USD 2,11,225.2 million in 2021 and is expected to reach USD 6,09,134 million by 2029, registering a CAGR of 12.4% during the forecast period of 2022 to 2029. The increasing demand for health screening will provide potential opportunities for the market growth in the forecast period.
Growing incidences of chronic diseases is anticipated to drive the market's growth rate
Chronic diseases are a primary factor that is surging the global demand for health screening. Growing cases of chronic diseases have positively impacted the demand for early screening. Therefore, the rise in chronic disease incidence is anticipated to boost the global health screening market in the forecast period. For instance, in 2017, as per the American Thoracic Society, about 16 million people in the U.S. had been diagnosed with Chronic Obstructive Pulmonary Disease (COPD) and this disease is the third most leading cause of death in the U.S. after heart diseases.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Test Type (Cholesterol Tests, Diabetes Test, Cancer Screening, General Check Up Test, STDs, Blood Pressure Test and Others), Package Type (Basic Health Screening, Senior Citizen Profile, Women Health Check, Men Health Check, Heart Check, Diabetes Check and Others), Panel Type (Multi-Test Panels and Single-Test Panels), Sample Type (Blood, Urine, Serum, Saliva and Others), Technology (Immunoassays, Medical Imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis) and Others), Condition (Cardiovascular Disease, Metabolic Disorders, Cancer, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions and Others), Sample Collection Sites (Hospital, Homes, Diagnostic Laboratories, Offices and Others), Distribution Channel (Direct Tenders, Retail Sales and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
|
|
Market Players Covered
|
Quest Diagnostics Incorporated (U.S.), Eurofins Scientific (Luxembourg), Exact Sciences Corporation (U.S.), SYNLAB International GmbH (Germany), UNILABS (Switzerland), LabPLUS (US), BioReference Laboratories (U.S.), Sonic Healthcare Limited (Australia), Cerba Healthcare (France), Quidel Corporation (U.S.), Innova Medical Group (US), Amedes Holding GmbH (Germany), Natera, Inc. (U.S.), Trinity Biotech (Ireland), RepeatDx (Canada), NeoGenomics Laboratories (U.S.), Q2 Solutions (U.S.), Genova Diagnostics (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
Global health screening market is categorized into eight notable segments which are based on test type, package type, panel type, sample type, technology, condition, sample collection sites and distribution channel.
- On the basis of test type, global health screening market is segmented into cholesterol tests, diabetes test, cancer screening, general checkup test, STDs, blood pressure test, and others.
The cholesterol tests segment of test type segment is anticipated to dominate the health screening market
The cholesterol tests segment is expected to dominate the global health screening market with 34.0% market share because of the increase in cardiac diseases and changing lifestyle patterns.
- On the basis of package type, global health screening market is segmented into basic health screening, senior citizen profile, women health check, men health check, heart check, diabetes check, and others.
The basic health screening segment of package type segment is anticipated to dominate the health screening market
The basic health screening segment is expected to dominate the global health screening market with 33.7% market share because of growing awareness among people for early diagnosis of disease and proper medication.
- On the basis of panel type, global health screening market is segmented into multi-test panels and single-test panels. The multi-test panels segment is expected to dominate the global health screening market with 82.6% market share as numerous laboratories and diagnostic centres use multi-test panels to screen for multiple substances at once.
- On the basis of sample type, global health screening market is segmented into blood, urine, serum, saliva, and others. The blood segment is expected to dominate the global health screening market with 45.3 % market share because blood test can help identify the functionality of the organs such as heart, kidneys, and liver among others.
- On the basis of technology, global health screening market is segmented into immunoassays, medical imaging, QPCR, Q-FISH, TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis), and others. The immunoassays segment is expected to dominate the global health screening market with 37.0 % market share because immunoassays are contributing in numerous applications which includes blood transfusions, implant operations, gene therapies, screening of infectious diseases and others.
- On the basis of condition, global health screening market is segmented into cardiovascular diseases, metabolic disorders, cancer, inflammatory conditions, musculoskeletal disorders, neurological conditions, hepatitis-C complications and immunology-related conditions, and others. The cardiovascular diseases segment is expected to dominate the global health screening market with 33.4% market share because of increasing incidence of cardiovascular diseases worldwide.
- On the basis of sample collection sites, global health screening market is segmented into hospital, home, diagnostic laboratories, offices, and others. The hospitals segment is expected to dominate the global health screening market with 36.2 % market share as hospitals have all the facilities to diagnose and treat the disorders.
- On the basis of distribution channel, global health screening market is segmented into direct tenders, retail sales, and others. The direct tenders segment is expected to dominate the global health screening market with 50.3 % market share because of increase in overall sales of health screening programs.
Major Players
Data Bridge Market Research recognizes the following companies as the major health screening market players in health screening market are Quest Diagnostics Incorporated (U.S.), Eurofins Scientific (Luxembourg), Exact Sciences Corporation (U.S.), SYNLAB International GmbH (Germany), UNILABS (Switzerland), LabPLUS (US), BioReference Laboratories (U.S.), Sonic Healthcare Limited (Australia), Cerba Healthcare (France), Quidel Corporation (U.S.), Innova Medical Group (US), Amedes Holding GmbH (Germany), Natera, Inc. (U.S.), Trinity Biotech (Ireland), RepeatDx (Canada), NeoGenomics Laboratories (U.S.), Q2 Solutions (U.S.), Genova Diagnostics (U.S.).
Market Development
- In 2021, Evoq Technologies LLC announced the launch of the first smartphone-based retinal health testing product. The "SmartERG" Platform is designed to evaluate the retinal health of the eye.
- In 2021, Eurofins Scientific SE's subsidiary Transplant Genomics announced the launch of OmniGraf. It integrates the Viracor TRAC donor-derived cell-free DNA assays with the TruGraf blood gene expression test. OmniGraf Kidney is the first diagnostic tool for renal transplant recipients that mixes cell-free DNA and gene expression data.
Regional Analysis
Geographically, the countries covered in the health screening market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
As per Data Bridge Market Research analysis:
North America is the dominant region in the health screening market during the forecast period 2022 to 2029
North America dominates the health screening market due to increasing government emphasis on preventive healthcare, growing chronic illness burden, and rising awareness of Healthy Life Expectancy (HALE). The U.S. held the largest share in the regional market because of the presence of major market players, increasing accessibility of telomere and oxidative stress tests, high usage of at-home testing alternatives, and increased awareness of rare diseases.
Asia-Pacific is estimated to be the fastest-growing region in the health screening market the forecast period 2022 to 2029
Asia-Pacific is expected to grow during the forecast period of 2022 to 2029 due to growing elderly population, increasing opportunities for major market players to expand, and an increase in the number of campaigns to increase awareness of healthy living and preventive healthcare in numerous Asian nations.
For more detailed information about health screening market report, click here – https://www.databridgemarketresearch.com/reports/global-health-screening-market
